The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“certain treatment suggestions that evolved during this period [76], such as garlic, malaria, and hydroxychloroquine”
From Psychosocial Effects of the COVID-19 Pandemic: Large-scale Quasi-Experimental Study on Social Media (2020) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731
Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651
Self-citationIn vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644
New insights into the antiviral effects of chloroquine
Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471
Self-citationRolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408
Self-citation
Cited by
Sorted by citations
Items 901–937 of 937
Hamouda, I. M. (2022) · International Journal of Clinical Case Reports · doi:10.31579/2834-8389/001
Viglione, D., & Thorp, J. A. (2023) · The Gazette of Medical Sciences · doi:10.46766/thegms.pubheal.22120905
Post Covid-19 Conditions after Dehospitalization according to Therapy
Ivanova, A. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.16.002242
Sharma, A. (2022) · Pharmaspire · doi:10.56933/pharmaspire.2022.14213
COVID-19: Molecular Pathogenesis and Prospective Therapeutic Interventions
Shrivastava, P., & Vyas, S. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-20537-8_12
Thangaraju, P., Venkatesan, S., Gurunthalingam, M. P., Velmurugan, H., Y, S. S. T., Thangadurai, D. K., Thangaraju, E., & Balasundaram, M. K. (2023) · Current Traditional Medicine · doi:10.2174/2215083810666230411093851
Complex therapy of patients with postviral syndrome and chronic fatigue syndrome
Карабаева, А. С. (2023) · Лечащий врач · doi:10.51793/os.2023.26.4.005
Sekiou, O., Kherfane, W., Boumendjel, M., Cheniti, H., Benselhoub, A., Stefano Bellucci, A., & INFN Frascati National Laboratories, R. (2023) · The Ukrainian Biochemical Journal · doi:10.15407/ubj95.01.090
Neves, F. S. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/1871526523666230522114836
Afshar, Z. M., Sayad, B., Janbakhsh, A., Ebrahimpour, S., & Babazadeh, A. (2023) · Minerva Respiratory Medicine · doi:10.23736/s2784-8477.21.01940-4
Outcome of COVID-19 in patients with rheumatic diseases treated with immunosuppressive drugs
Sobh, A., Elnagdy, N. H., Elegezy, M., Mofreh, M., Tohlob, M. A., Eita, A. M., Rizk, R., Eliwa, O., Elnagdy, M. H., & Abdulgalil, A. E. (2023) · Mansoura Medical Journal · doi:10.58775/2735-3990.1391
Silva, W. D. S., & Deleprani, F. O. (2023) · Policromias - Revista de Estudos do Discurso, Imagem e Som · doi:10.61358/policromias.v8i1.56154
Review of Covid-19's Current Development in Therapeutic and Diagnostic Techniques
Keerthika, S., Kowsalya, M., Kameswaran, R., & Venkateswaramurthy, N. (2023) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3195
How COVID-19 and malaria are strikingly alike: A short review
Hidig, S. M. (2024) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2024.21.1.0037
O’Regan, R., Harnedy, F., Reynolds, B., & Cormican, L. J. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03597-y
Bravo, O. E. J., Arias, R. A. C., Vasquez, J. C., & Sánchez-Zamora, V. R. (2022) · Killkana Salud y Bienestar · doi:10.26871/killcanasalud.v6i3.622
A Review: Suppressed Activity Of Respiratory System After Covid-19
Bysack, M., Sengupta, A., Ash, B., Patra, P., Ballav, A., Das, S., & Ganguly, P. (2024) · Journal Of Advanced Zoology · doi:10.53555/jaz.v45i2.4456
Role of Ivermectin and Colchicine in Treatment of COVID-19: A Randomized Controlled Clinical Trial
alnaga, F. A. A. (2024) · International Journal of Biological Engineering and Agriculture · doi:10.51699/ijbea.v3i1.3296
An arsenal of naturopathic compounds for the treatment of COVID-19: A comprehensive review
Tepe, M., Erol, K. F., Karadağ, A. E., & Güzel, M. (2024) · Journal of Phytomolecules and Pharmacology · doi:10.56717/jpp.2024.v03i01.023
Alsofyani, I. S., Samman, B. S., Alhubayshi, S. S., Ellahi, A. T., Alsaedi, A. B., & Almansour, M. (2024) · Cureus · doi:10.7759/cureus.60128
Kepeňová, M., Benediková, M., Kello, M., Medvecová, V., Samoľová, E., Litecká, M., Vilková, M., & Potočňák, I. (2025) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202500141
Impact of nano biomaterials as PPE coatings to prevent COVID-19: A review article
Verma, G., Awasthi, S., Sharma, K., & Gupta, A. (2025) · AIP conference proceedings · doi:10.1063/5.0240619
Chen, J., Weichao, D., Chen, K., Li, Q., Xingdong, C., Zhang, Z., Zhang, L., Shinan, N., Mengmeng, W., & Zhaorui, S. (2025) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265391729250831063548
Additional file 4 of SAveRUNNER: an R-based tool for drug repurposing
Fiscon, G., & Paci, P. (2021) · Figshare · doi:10.6084/m9.figshare.14302890
Additional file 3 of SAveRUNNER: an R-based tool for drug repurposing
Fiscon, G., & Paci, P. (2021) · Figshare · doi:10.6084/m9.figshare.14302887
Quinn, T. J., Burton, J. K., Carter, B., Cooper, N. J., Dwan, K., Field, R., Freeman, S. C., Geue, C., Hsieh, P.-H., McGill, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14091124
Liu, Y., Rong, L., Ailikaiti, A., Zhao, X., Zhang, W., & Wang, H. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.111927
ATP6V0C–HIF-1α reciprocal activation drives acute lung injury
Hu, Y., Wang, Y., Ren, C., Liu, S., Huang, R., Sun, T., Zhao, Z., Duan, Z., Yin, J., Jiang, T., et al. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag016
Circadian rhythm involvement in the host immune response
Diallo, A. B. (2020) · theses.fr (ABES) · doi:10.70675/d0ae13c6zedf6z402cz9fbfz469e58c326a0
Pathophysiological study of Tropheryma whipplei infections
Boumaza, A. F. (2021) · theses.fr (ABES) · doi:10.70675/d5f58b7cz43a0z4857za270zcb40959daf0d
Exploration of autophagy modulation in cancer and infectious diseases
Bestion, E. (2021) · theses.fr (ABES) · doi:10.70675/3663f1cdz2637z4b11za0afza7e39569a2fc
Premières étapes dans l'interaction hôte-pathogène : rôle de l'immunité locale et innée
Michel, M. (2022) · theses.fr (ABES) · doi:10.70675/4647f4d2zd802z40abza572z8ff228db523f
Strategies for drug repurposing in COVID-19
Kokudeva, M., Velikova, T. V., & Момеков, Г. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e197010
Topological Characterization of Diuretic Agents With QSPR-Based Regression Prediction
Shabbir, K., Ahmad, K., & Saleem, D. A. (2026) · Punjab University Journal of Mathematics · doi:10.52280/pujm.2026.58(05)01
BindingDB Entry 50018381: COVID-19 therapy: What weapons do we bring into battle?
BindingDB (2024) · UC San Diego · doi:10.7270/q2v410dh
Metadata
- Authors
- Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D.
- Affiliations
- Aix-Marseille Université (FR)
- Corresponding author
- Raoult, Didier
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 55
- Issue
- 4
- Pages
- 105932
- ISSN
- 0924-8579 (ISSN-L)
- PMC
- PMC7135139
- OpenAlex
- W3010277308
- Cited by
- 937
- References
- 26
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 21 · 2023: 45 · 2022: 71 · 2021: 215 · 2020: 564
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- International Journal of Antimicrobial Agents (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IAHU-0003)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Keywords
- chloroquine, hydroxychloroquine, COVID-19 pandemic, SARS-CoV-2, antimalarial drugs, antiviral therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adenosine Monophosphate, Alanine, Chloroquine, Hydroxychloroquine, Pneumonia, Viral, Coronavirus, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
